Carcinotech

Carcinotech is a pioneering MedTech company specializing in the manufacturing of 3D printed mini tumours derived from patient-specific cancer stem cells, primary cells, and established cell lines. Operating in the healthcare and biotechnology market, Carcinotech serves pharmaceutical companies, research institutions, and healthcare providers focused on cancer treatment and drug discovery. The company's business model revolves around providing advanced 3D tumour models that facilitate rapid, ethical, and accurate drug discovery, screening, and preclinical testing. Revenue is generated through the sale of these customized 3D models, which offer high throughput capabilities and can be tailored to specific research needs. Carcinotech leverages AI-driven automated manufacturing to accelerate production and ensure high-quality outputs. The company aims to be at the forefront of patient-specific drug discovery and screening, paving the way for more effective cancer treatments.

Keywords: 3D printing, mini tumours, cancer research, drug discovery, preclinical testing, patient-specific, AI-driven, automated manufacturing, biotechnology, healthcare.